Park Pyeongtak
Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
Latest Articles
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Powered by 